Sheuli Chowdhury
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sheuli Chowdhury has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Matthew Q. Dao
John Sealy School of Medicine, University of Texas Medical Branch, Galveston, TX 77555, USA
2 shared publications - Paul Won
Division of Plastic Surgery, Department of Surgery, McGovern Medical School, University of Texas Health Science Center at Houston , 6431 Fannin St, Houston, TX 77030
2 shared publications Abigail R Tirrell
1 shared publication- Alice Yao
Division of Plastic and Reconstructive Surgery, Department of Surgery, Icahn School of Medicine at Mount Sinai , 10 Union Square East, Suite 2 L, New York, NY 10003
1 shared publication - Amina El Ayadi
Department of Surgery, The University of Texas Medical Branch, Galveston, TX 77555, USA
1 shared publication BaiJing Qin
1 shared publication
Latest Publications
- 9 October 2025
- Published by Oxford University Press (OUP) in Journal of Burn Care & Research
- Vol. 47 (2) , 573-581
Serotonergic Antidepressant Use After Recent Facial Burn Injury is Associated with Hypertrophic Scarring, Metabolic Complications, and Reduced Mortality
Facial burns can cause profound psychological distress, often treated with selective serotonin reuptake inhibitors or serotonin-norepinephrine reuptake inhibitors. While their psychiatric benefits are established, their impact on wound healing and long-term outcomes is less defined. This study examines associations between early serotonergic antidepressant exposure and physiological complications following facial burn injury. Adult patients with second- or third-degree facial burns (2010-2025) were identified in the TriNetX US Collaborative Network. Those prescribed antidepressants within one month of injury were compared to controls without antidepressant use. Propensity score–matching was performed based on demographics, burn characteristics, and psychiatric as well as medical comorbidities. Outcomes assessed at 90 days, 180 days, and 1 year included skin infection, hypertrophic scarring, lactic acidosis, hyperglycemia, hypoglycemia, and mortality. Univariate regression analyses were used to compare each outcome, with significance defined as P < .05. Of 46 971 facial burn patients identified, 3392 remained in each group after matching. Patients in the matched antidepressant group had significantly higher rates of hypertrophic scarring and skin infection at all time points compared to those in the matched control group (P < .01). Additionally, lactic acidosis and hyperglycemia became elevated beginning at 180 days (P < .05) among patients who were prescribed antidepressants. Mortality, however, was consistently lower in the matched antidepressant group at all time intervals (P < .05). Early serotonergic antidepressant use after facial burn injury is linked to increased risk of hypertrophic scar formation, infection, and metabolic disturbances, yet decreased rates of mortality.
- 9 October 2025
- Published by Oxford University Press (OUP) in Journal of Burn Care & Research
- Vol. 47 (2) , 573-581
Serotonergic Antidepressant Use After Recent Facial Burn Injury is Associated with Hypertrophic Scarring, Metabolic Complications, and Reduced Mortality
Facial burns can cause profound psychological distress, often treated with selective serotonin reuptake inhibitors or serotonin-norepinephrine reuptake inhibitors. While their psychiatric benefits are established, their impact on wound healing and long-term outcomes is less defined. This study examines associations between early serotonergic antidepressant exposure and physiological complications following facial burn injury. Adult patients with second- or third-degree facial burns (2010-2025) were identified in the TriNetX US Collaborative Network. Those prescribed antidepressants within one month of injury were compared to controls without antidepressant use. Propensity score–matching was performed based on demographics, burn characteristics, and psychiatric as well as medical comorbidities. Outcomes assessed at 90 days, 180 days, and 1 year included skin infection, hypertrophic scarring, lactic acidosis, hyperglycemia, hypoglycemia, and mortality. Univariate regression analyses were used to compare each outcome, with significance defined as P < .05. Of 46 971 facial burn patients identified, 3392 remained in each group after matching. Patients in the matched antidepressant group had significantly higher rates of hypertrophic scarring and skin infection at all time points compared to those in the matched control group (P < .01). Additionally, lactic acidosis and hyperglycemia became elevated beginning at 180 days (P < .05) among patients who were prescribed antidepressants. Mortality, however, was consistently lower in the matched antidepressant group at all time intervals (P < .05). Early serotonergic antidepressant use after facial burn injury is linked to increased risk of hypertrophic scar formation, infection, and metabolic disturbances, yet decreased rates of mortality.
- Open Access
- 8 January 2025
- Published by Oxford University Press (OUP) in Aesthetic Surgery Journal Open Forum
- Vol. 7, ojaf141
Recent COVID-19 Infection Increases Complication Risk After Body-Contouring Surgery
Background: Although COVID-19 infection rates have declined from pandemic peaks, recent infection may pose a potential concern in aesthetic surgery. Of note, the surgical risks associated with recent infection are not well defined. Previous studies, constrained by small cohorts and early-pandemic data, have not conclusively established whether recent COVID-19 infection continues to influence surgical outcomes. Objectives: The authors sought to determine whether COVID-19 infection within 30 days before body-contouring procedures is associated with increased postoperative complications. Methods: Adult patients who underwent body-contouring surgery between August 2020 and March 2025 were identified from the US Collaborative Network on TriNetX (TRINETX, LLC, Cambridge, MA). Patients were categorized based on documented COVID-19 infection within 30 days preoperatively. Propensity score matching (1:1) was performed to balance demographics and comorbidities. Thirty-day postoperative complications were compared using risk ratios (RRs), with statistical significance defined as P < .05. Results: A total of 3941 patients were matched in each of the COVID-19 and non-COVID-19 groups. Patients in the matched COVID-19 group had a significantly increased risk of surgical-site infection (RR 1.56, P = .010), wound disruption (RR 1.69, P = .003), postoperative pain (RR 1.66, P = .002), anticoagulant use (RR 1.77, P < .0001), and emergency department visits (RR 1.50, P = .010). Conclusions: Despite reduced overall prevalence, recent COVID-19 infection remains associated with increased risk of postoperative complications following body-contouring surgery. Delaying elective aesthetic procedures by at least 30 days following recent infection appears prudent to enhance patient safety and minimize complications. Level of Evidence: 3 (Therapeutic):
- 8 January 2025
- Published by Oxford University Press (OUP) in Aesthetic Surgery Journal Open Forum
- Vol. 7, ojaf141
Open AccessRecent COVID-19 Infection Increases Complication Risk After Body-Contouring Surgery
Background: Although COVID-19 infection rates have declined from pandemic peaks, recent infection may pose a potential concern in aesthetic surgery. Of note, the surgical risks associated with recent infection are not well defined. Previous studies, constrained by small cohorts and early-pandemic data, have not conclusively established whether recent COVID-19 infection continues to influence surgical outcomes. Objectives: The authors sought to determine whether COVID-19 infection within 30 days before body-contouring procedures is associated with increased postoperative complications. Methods: Adult patients who underwent body-contouring surgery between August 2020 and March 2025 were identified from the US Collaborative Network on TriNetX (TRINETX, LLC, Cambridge, MA). Patients were categorized based on documented COVID-19 infection within 30 days preoperatively. Propensity score matching (1:1) was performed to balance demographics and comorbidities. Thirty-day postoperative complications were compared using risk ratios (RRs), with statistical significance defined as P < .05. Results: A total of 3941 patients were matched in each of the COVID-19 and non-COVID-19 groups. Patients in the matched COVID-19 group had a significantly increased risk of surgical-site infection (RR 1.56, P = .010), wound disruption (RR 1.69, P = .003), postoperative pain (RR 1.66, P = .002), anticoagulant use (RR 1.77, P < .0001), and emergency department visits (RR 1.50, P = .010). Conclusions: Despite reduced overall prevalence, recent COVID-19 infection remains associated with increased risk of postoperative complications following body-contouring surgery. Delaying elective aesthetic procedures by at least 30 days following recent infection appears prudent to enhance patient safety and minimize complications. Level of Evidence: 3 (Therapeutic):